Markets › Stocks › FREDUN
FR

Fredun Pharmaceuticals Ltd

NSE: FREDUNBSE: 539730Healthcare
Download Research Report7-page PDF
₹2,255.95
▼ -2.29%
NSE · auto-updates while market open
Mkt Cap
₹1,209 Cr
P / E
32.3
P / B
4.3
ROE
17.9%
52W High
₹2,620.00
52W Low
₹707.90
Key Metrics
Market Cap
₹1,209 Cr
P / E
32.29
P / B
4.34
EV / EBITDA
16.01
ROCE
21.3%
ROE
17.9%
Debt / Equity
0.80
Book Value
₹508.17
EPS
₹66.81
Div Yield
0.0%
Face Value
-
Promoter Holding
44.6%
Revenue · ₹ Cr
110
FY20
132
FY21
222
FY22
274
FY23
347
FY24
452
FY25
633
FY26
Net Profit · ₹ Cr
8
FY20
2
FY21
6
FY22
11
FY23
16
FY24
20
FY25
33
FY26
EPS · ₹ per share
₹4.8
FY20
₹5.0
FY21
₹14.3
FY22
₹22.9
FY23
₹33.7
FY24
₹44.8
FY25
₹66.8
FY26
Q1 2026 snapshot
Sales
₹213 Cr
Operating profit
-
OPM
-
Net profit
₹11 Cr
EPS
₹19.70
Scorecard · 7 axes
Quality
Strong
83/100
Valuation
Avg
32.3×
Growth
Strong
+40.3%
Profitability
Good
19.6%
Performance
Strong
+216.0%
Entry Point
Avg
86%
Red Flags
Strong
0 flags
Shareholding Pattern
44.6%Promoter
Promoter44.6%
FII1.1%
DII2.8%
Public51.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue102.7167.41119.86145.29160.92213.06
Net Profit5.3336.0046.7669.43210.47810.78
NPM %5.2%3.6%5.6%6.5%6.5%5.1%
AlertPre-trade